title: [Chronic rejection: Differences and similarities in various solid organ transplants].
abstract: In this paper, chronic rejections after transplantation of the lungs, heart, liver, and kidney are described. Chronic allograft dysfunction (CAD) plays an important role in all of these transplantations and has a significant influence on patient survival. The pathophysiological reasons for CAD varies greatly in the various organs.Chronic lung allograft dysfunction (CLAD) is the most important determinant of survival and quality of life after lung transplantation. Diagnosis is based on lung function, especially forced expiratory flow in 1 s (FEV1) decline. Prevention, early detection, and rapid treatment are extremely important. Azithromycin and extracorporeal photopheresis are commonly used for treatment because they usually positively influence the progression of lung remodeling.The expression for chronic rejection of the heart is cardiac allograft vasculopathy (CAV). Immunological and nonimmunological factors are important for its development. Due to limited therapeutic options, prevention is of utmost importance (administration of mTOR inhibitors and minimizing cardiovascular risk factors).The mid- and long-term survival rates after liver transplantation have hardly changed in recent decades, which is an indication of the difficulty in diagnosing chronic graft dysfunction. Chronic ductopenic rejection accounts for a small proportion of late graft dysfunction. Idiopathic posttransplant hepatitis and de novo autoimmune hepatitis are important in addition to recurrence of the underlying disease that led to transplantation.Chronic allograft nephropathy is the result of severe rejection which cumulates in increasing fibrosis with remodeling. The earliest possible diagnosis and therapy is currently the only option. Diagnosis is based on evidence of donor-specific antibodies and histological findings.
authors.affiliation: Klinik für Pneumologie, Zentrum Innere Medizin, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland. suhling.hendrik@mh-hannover.de.
authors.forename: H
authors.initials: H
authors.lastname: Suhling
authors.affiliation: Klinik für Pneumologie, Zentrum Innere Medizin, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland.
authors.forename: J
authors.initials: J
authors.lastname: Gottlieb
authors.affiliation: Klinik für Herz-, Thorax-, Transplantations- und Gefäßchirurgie (HTTG), Zentrum Chirurgie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland. bara.christoph@mh-hannover.de.
authors.forename: C
authors.initials: C
authors.lastname: Bara
authors.affiliation: Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Zentrum Innere Medizin, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland.
authors.forename: R
authors.initials: R
authors.lastname: Taubert
authors.affiliation: Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Zentrum Innere Medizin, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland. jaeckel.elmar@mh-hannover.de.
authors.forename: E
authors.initials: E
authors.lastname: Jäckel
authors.affiliation: Klinik für Nieren- und Hochdruckerkrankungen, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland. schiffer.mario@mh-hannover.de.
authors.forename: M
authors.initials: M
authors.lastname: Schiffer
authors.affiliation: Institut für Pathologie, Medizinische Hochschule Hannover, Hannover, Deutschland.
authors.forename: J H
authors.initials: JH
authors.lastname: Bräsen
mesh_terms: D015984:Causality; D002908:Chronic Disease; D006084:Graft Rejection / Q000401:mortality*; D006331:Heart Diseases / Q000401:mortality*; D006801:Humans; D007674:Kidney Diseases / Q000401:mortality*; D008107:Liver Diseases / Q000401:mortality; D008171:Lung Diseases / Q000401:mortality*; D016377:Organ Transplantation / Q000401:mortality*; D011183:Postoperative Complications / Q000401:mortality*; D015995:Prevalence; D012307:Risk Factors; D015996:Survival Rate
keywords: Allograft vasculopathy; Autoimmune hepatitis; Chronic allograft dysfunction; Humoral rejection; Immunosuppression